Malcolm Brenner
机构: Professor of Medicine, Baylor College of Medicine
每年引用次数
引用次数
引用: 65,029
H-指数: 128
I10-指数 : 452
出版物: 1,166
Autologous bone-marrow transplantation in childhood acute lymphoblastic leukaemia
MalcolmK. Brenner
The Lancet 346 ( 8979) 856 -857
5
1995
CYTOMEGALOVIRUS PNEUMONITIS AFTER ALLOGENEIC MARROW TRANSPLANTATION
MalcolmK. Brenner , PaulD. Griffiths , H.Grant Prentice
The Lancet 330 ( 8553) 286 -287
1987
General Discussion I
Alpert , Gordon , B. Brenner , Godt
Advances in Experimental Medicine and Biology 453 577 -600
1998
Prolonged remission of Epstein-Barr virus associated lymphoma secondary to T cell-depleted bone marrow transplantation.
S. Hamilton-Dutoit , M. P. A. Lyttelton , J. O. D. Mcgee , M. K. Brenner
Bone Marrow Transplantation 3 ( 6) 641 -646
3
1988
Interleukin-2 infusion after autologous bone marrow transplantation enhances hemopoietic regeneration.
H. E. Heslop , M. K. Brenner , A. V. Hoffbrand , D. J. Gottlieb
International congress of the transplantation society 23 ( 1) 1704 -1705
5
1991
CMV-induced augmentation of GVL effect may be mediated by cytokines.
M. K. Brenner , J. E. Grundy , H. G. Prentice , A. S. Duncombe
Bone Marrow Transplantation 7 ( 1) 69 -69
1991
Use of safety modified retroviruses to improve the outcome of bone marrow transplantation
C. M. Rooney , D. R. Rill , M. K. Brenner , C. A. Smith
Bone Marrow Transplantation 15 ( 1)
1995
L'élimination des cellules malignes du transplant médullaire par les anticorps monoclonaux
J. P. Grob , M. K. Brenner , H. G. Prentice
Medecine Et Hygiene 43 ( 1609) 1597 -1601
1985
T cell stimulation with different cytokines results in distinct phenotypes and cytotoxic activity of CD19-specific CART cells
C. Kleist , P. Dreger , Angelica Loskog , A. Schmitt
Onkologie 39 136 -136
2016
Epstein Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes (CTL) Expressing an Anti-CD30 Chimeric T Cell Receptor (CTCR) for the Treatment of Hodgkin’s Disease (HD).
B. Savoldo , C. M. Rooney , H. E. Heslop , H. Abken
Blood 104 ( 11) 745 -745
2004
Tumour necrosis factor.
M. K. Brenner
British Journal of Haematology 69 ( 2) 149 -152
29
1988
Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation.
C. M. Rooney , J. Z. Wimperis , M. K. Brenner , J. Patterson
British Journal of Haematology 62 ( 3) 413 -420
64
1986
Production of anti‐cytomegalovirus antibody following T‐cell depleted bone marrow transplant
J. Z. Wimperis , N. J. Berry , M. K. Brenner , J. Grundy
British Journal of Haematology 63 ( 4) 659 -664
9
1986
Standardization of T-cell depletion in HLA matched bone marrow transplantation.
M. J. M. L. Gilmore , J. Patterson , K. Ivory , M. K. Brenner
British Journal of Haematology 64 ( 1) 69 -75
10
1986
Recovery of immurioglobulin isotypes following T‐cell depleted allogeneic bone marrow transplantation
M. K. Brenner , J. Z. Wimperis , J. E. Reittie , J. Patterson
British Journal of Haematology 64 ( 1) 125 -132
28
1986
Cytokine-induced enhancement of the susceptibility of hairy cell leukaemia lymphocytes to natural killer cell lysis.
F. T. Cordingley , A. V. Hoffbrand , M. K. Brenner
British Journal of Haematology 70 ( 1) 37 -41
14
1988
Possible mechanism of action of interferon alpha in chronic B-cell malignancies
H. E. Heslop , M. K. Brenner , K. Ganeshaguru , A. V. Hoffbrand
British Journal of Haematology 79 ( s1) 14 -16
12
1991
The contribution of large granular lymphocytes to B cell activation and differentiation after T-cell-depleted allogeneic bone marrow transplantation.
M. K. Brenner , J. E. Reittie , J-P. Grob , J. Z. Wimperis
Transplantation 42 ( 3) 257 -261
40
1986
A distinct "side population" of cells with high drug efflux capacity in human tumor cells.
C. Hirschmann-Jax , A. E. Foster , G. G. Wulf , J. G. Nuchtern
Proceedings of the National Academy of Sciences of the United States of America 101 ( 39) 14228 -14233
1,115
2004
Cellular therapy for cancer: let there be light.
M. K. Brenner
Tissue Antigens 79 ( 1) 1 -3
2012